Advanced glycation of β2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 86-90

  Miyata, T ^a   Sprague, S M ^b,c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

Advanced glycation end products; Bone resorption; Dialysis associated amyloidosis; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; BONE LESION; CONFERENCE PAPER; DIALYSIS; GLYCATION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029756170     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.86     Document Type: Conference Paper

References (37)

1. 2-microglobulin a mediator of bone disease? Kidney Intern 1995; 47: 1-6
2. 2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701-706
3. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-1252
4. 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 1986; 83: 7908-7912
5. 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989; 36: 675-681
6. 2-microglobulin in AB-amyloid in situ. Kidney Int 1993; 43: S100-S105
7. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
8. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1990; 325: 836-842
9. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-9014
10. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 1992; 89: 2873-2877
11. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994; 91: 4766-4770
12. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretions of tumor necrosis factor-α and interleukin-1. J Clin Invest 1994; 93: 521-528
13. 2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophy Res Commun 1994; 201: 1235-1241
14. 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. Biochemistry 1994; 33: 12215-12221
15. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-I induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240: 1546-1548
16. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan Y-CE, Elliston K, Stern D, Shaw A. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267: 14998-15006
17. Baynes JW. Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412
18. 2-microglobulin on bone resorption. Am J Kidney Dis 1994; 23: 726-730
19. 2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am J Physiol 1992; 263: F540-F545
20. 2-microglobulin stimulates osteoclastic mediated bone mineral dissolution from neonatal mouse calvariae. Calcium Reg Horm Bone Metab 1992; 11: 302-306
21. McCarthy TL, Centrella M, Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1989; 124: 1247-1253
22. 2-microglobulin on human bone-derived cells in vitro. Biochem Biophys Res Comm 1991; 175: 795-803
23. Canalis E, McCarthy T, Centrella T. Growth factors and the regulation of bone remodeling. J Clin Invest 1988; 81: 277-281
24. Vaes G. Cellular biology and biochemical mechanism of bone resorption: a review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop Rel Res 1988; 231: 239-271
25. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG, An interleukin I like factor stimulates bone resorption in vitro. Nature 1983; 306: 378-380
26. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993; 260: 626-627
27. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986; 319: 516-518
28. Dinarello CA, Koch KM, Shaldon S. Interleukin-I and its relevance in patients treated with hemodialysis. Kidney Int 1988; 33: S21-S26
29. 2-microglobulin. Am J Nephrol 1992; 12: 330-335
30. 2-microglobulin proteins. Science 1989; 243: 655-657
31. 2-microglobulin induced bone mineral dissolution. Kidney Int 1995; 47: 587-591
32. 2-microglobulin amyloidosis. Am J Kidney Dis 1992; 19: 427-432
33. 2-microglobulin. Proc Natl Acad Sci USA 1985; 82: 4225-4229
34. 2-microglobulin. Biochem Biophys Res Commun 1985; 131: 1063-1068
35. 2-microglobulin. J Biol Chem 1981; 256: 10949-10953
36. 2-microglobulin amyloid fibrils. Am J Pathol 1992; 141: 241-248
37. 2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989; 53: 37-40